Bexorg: Funding, Investors & Team (Sep 2026)
Bexorg provides a technology platform for central nervous system drug discovery and development.
Bexorg has raised $23.0M across 1 funding round on record, the most recent a Series A of $23.0M announced in Oct 2025.
That round is in line with the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bexorg Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Bexorg Funding Rounds
Bexorg Founders and Leadership Team
Contact details for the Bexorg team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Bexorg Funding Compared to Other Biotechnology Startups
Bexorg's latest round of $23.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bexorg in Biotechnology and San Francisco
Companies Similar to Bexorg
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Bexorg Funding FAQs
What does Bexorg do?
Bexorg provides a technology platform for central nervous system drug discovery and development.
How much funding has Bexorg raised?
Bexorg has raised $23.0M across 1 round on record. The most recent is a Series A of $23.0M announced in Oct 2025.
When did Bexorg last raise funding?
Bexorg's most recent funding round on record is a Series A of $23.0M, announced in Oct 2025.
Who is the CEO of Bexorg?
Zvonimir Vrselja is listed as CEO at Bexorg.
Where is Bexorg headquartered?
Bexorg is based in San Francisco, United States.
How many employees does Bexorg have?
Bexorg is in the 11-50 employee band.
How does Bexorg's funding compare to other Biotechnology startups?
Bexorg's latest round of $23.0M is in line with the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Bexorg Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bexorg is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.